CURRICULUM VITAE Sunil V. Rao, MD FACC - TransradialWorld

transradialworld.com

CURRICULUM VITAE Sunil V. Rao, MD FACC - TransradialWorld

CURRICULUM VITAE

Sunil V. Rao, MD FACC FSCAI

Current Positions: Assistant Professor of Medicine, Duke University

Medical Center

Director, Cardiac Catheterization Laboratories

Durham Veterans Affairs Medical Center

Durham, North Carolina

Contact Information:

Home 105 Graylyn Drive

Chapel Hill, NC 27516

919-968-4278

Office Durham VA Medical Center

508 Fulton Street (111A)

Room A3023

Durham, NC 27705

Phone 919-684-8111

Fax 919-286-6821

Pager 919-970-2393

Email sunil.rao@duke.edu

Date and Place of birth:

March 23, 1971

New York, New York

USA

Marital Status:

Married, wife Caroline Hebert Rao MD

Staff Dermatologist

Durham VA Medical Center

Durham, North Carolina

Children:

Licensure:

Maya, born 2/27/1999

Lillian, born 3/19/2001

Ava, born 10/16/2003

Grace, born 8/31/2006

North Carolina Medical Board

Page 1 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


License number: 9900329

Issued: March 1999

Board Certification:

Board certification in Internal Medine 1999

Medical Training:

Education:

Board certification in Cardiovascular Disease 2005

Board Certification in Interventional Cardiology 2007

Warren S. & Gloria R. Newman Fellow in Interventional

Cardiology

Division of Cardiology

Duke University Medical Center

2003-2004

Cardiology Fellow

Division of Cardiology

Duke University Medical Center

1999-2003

Chief Fellow, Cardiology

Division of Cardiology

Duke University Medical Center

2001-2002

Resident, Internal Medicine

Department of Internal Medicine

Duke University Medical Center

1997-1999

Intern, Internal Medicine

Department of Internal Medicine

Duke University Medical Center

1996-1997

Doctor of Medicine (M.D.), 1996

The Ohio State University College of Medicine

Columbus, Ohio

Page 2 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


Bachelor of Arts, Zoology (B.A.), 1992

Miami University

Oxford, Ohio

Honors and Awards:

Duke University Medical Center

• Warren S. & Gloria R. Newman Fellowship in Interventional

Cardiology

• Outstanding Senior Resident Talk – “Ventricular Tachycardia”

1999

• Senior Resident Research Presentation, Medical Grand Rounds

– “Patterns of Use of Stress Testing in Unstable Angina/Non Q-

Wave MI: Insights from GUSTO IIa,” 1999

• Finalist, Resident Mentor Award, 2008

The Ohio State University Medical Center

• Graduated Magna Cum Laude 1996

• The David Saylor Memorial Award for Cardiology Research

1996

• Honors, Lecture-discussion curriculum 1993-1994

• The James W. Thurber Fellowship for Research in

Ophthalmology 1993

• Honors, Gross anatomy and embryology 1992-1993

• Honors, Cell & tissue biology 1992-1993

• Honors, Neuroscience 1992-1993

Miami University

• Graduated Summa Cum Laude and With Honors (GPA 3.97)

1992

• President’s List (4.0 GPA) 7 of 8 semesters

• Dean’s List (3.5-3.9 GPA) 1 semester

Honor Societies:

The Ohio State University College of Medicine

• Alpha Omega Alpha, Gamma chapter 1996

• The American Pathology Chairpersons Pathology Honor Society

1993

Miami University

• Phi Beta Kappa 1992

• Phi Kappa Phi 1991

National professional society membership

Page 3 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


• Member, American College of Cardiology Scientific Sessions

planning committee 2007-2010

• Faculty, Transcatheter Cardiovascular Therapeutics (TCT)

Annual conference 2005-present

• Faculty, Transcatheter Cardiovascular Therapeutics Annual

Interventional Fellows’ Course, 2007-present

• Fellow, American College of Cardiology

• Fellow, Society for Cardiac Angiography and Interventions

Editorial board memberships

• Associate editor, The American Heart Journal

Ongoing Research Support

• HHS-N-260-2005-00010-C

o NIH/NIA

o 9/30/2005 – present

o Title and goal: Reduction in Infarct Expansion and

Ventricular Remodeling with Erythropoietin After Large

Myocardial Infarction (REVEAL); a phase II randomized

trial of intravenous erythropoietin after successful primary

or rescue PCI

o Role: Co-Investigator

• American College of Cardiology

o 6/2006 – present

o Title: ACC National Cardiovascular Data Registry

o Role: Co-Investigator

• Cordis Corporation

o 11/2006 – present

o Title: Accessing Chronic Total Occlusions with the

Sirolimus Stent (ACROSS) Study

o Role: National Principal Investigator

• Population Health Research Institute (McMaster University)

o 1/2009-present

o Title: FUTURA Trial

o Role: US National Coordinator, Steering Committee

member

Page 4 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


• Portola Pharmaceuticals

o 6/2008 – present

o Title: A Randomized, Double-Blind, Active-Controlled

Trial to Evaluate Intravenous and Oral PRT060128, a

Selective and Reversible P2Y12-Receptor Inhibitor, vs.

Clopidogrel, as a Novel Antiplatelet Therapy in Patients

Undergoing Non-Urgent Percutaneous Coronary

Interventions (INNOVATE-PCI)

o Role: National Principal Investigator

Abstracts, Posters, and Presentations:

“Elevated cardiac markers across a spectrum of patients with chest pain:

Defining the role of isolated troponin or CKMB elevation.” November 14, 2001.

Anaheim, California. Oral presentation at the American Heart Association 2001

Scientific Sessions.

“Poverty, Process of care, and Outcomes in Acute Coronary Syndromes.” March

17, 2002. Atlanta, Georgia. Poster presented as part of the American College of

Cardiology 51 st Annual Scientific Sessions.

“Bleeding Among Patients with Acute Coronary Syndromes is Associated with a

Higher Risk of Short- and Long-term Death.” November 9, 2004. New Orleans,

Louisiana. Poster presented as part of the American Heart Association 2004

Scientific Sessions.

“On- versus Off-label Use of Drug-Eluting Stents in Clinical Practice: Data from

the American College of Cardiology-National Cardiovascular Disease Registry.”

November 10, 2004. New Orleans, Louisiana. Oral presentation at the

American Heart Association 2004 Scientific Sessions.

“Predictors of Drug-Eluting Stent Use in Clinical Practice: A Report from the

American College of Cardiology-National Cardiovascular Disease Registry.”

November 10, 2004. New Orleans, Louisiana. Oral presentation at the

American Heart Association 2004 Scientific Sessions.

“Predictors of major bleeding and transfusion in the SYNERGY trial: Effect of

pretreatment variables and treatment assignment.” March 9, 2005. Orlando,

Florida. Oral presentation at the American College of Cardiology 2005 Scientific

Sessions.

“Bleeding and blood transfusion rates are higher among acute coronary

syndrome patients in the United States than in other countries.” November 15,

2005. Dallas, Texas. Poster presentation at the American Heart Association

2005 Scientific Sessions.

Page 5 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


“Revascularization improves survival compared with medical therapy among

patients with rheumatologic disease and coronary artery disease.” November 14,

2006. Chicago, Illinois. Poster presentation at the American Heart Association

2006 Scientific Sessions.

“The radial approach to percutaneous coronary intervention is associated with a

lower risk for complications regardless of radial procedure volume: A report from

the American College of Cardiology National Cardiovascular Data Registry.”

March 25, 2007. New Orleans, LA. E-Poster presentation at the American

College of Cardiology 2007 Scientific Sessions.

“Bleeding and blood transfusion are major drivers of cost among patients with

acute coronary syndromes.” March 27, 2007. New Orleans, LA. Oral

presentation at the American College of Cardiology 2007 Scientific Sessions.

“Incidence and short-term outcomes of drug-eluting stent fracture in chronic total

occlusions: An analysis from the ACROSS-Cypher Trial.” Chicago, IL. Oral

presentation at the American College of Cardiology 2008 Scientific Sessions.

“Clinical and angiographic outcomes with sirolimus-eluting stents in total

coronary occlusions: ACROSS/TOSCA-4 Trial.” Chicago, IL. Oral presentation

at the American College of Cardiology 2008 Scientific Sessions.

“Lack of impact of randomized trials on percutaneous coronary intervention

practice: Data from the National Cardiovascular Data Registry.” Chicago, IL.

Oral presentation at the American College of Cardiology 2008 Scientific

Sessions.

“Annual case volume is not a strong predictor of bleeding after percutaneous

coronary intervention: A report from the National Cardiovascular Data Registy.”

Orlando, FL. Poster presentation at the American College of Cardiology 2009

Scientific Sessions.

“Evaluation of M118 in Percutaneous Coronary Intervention: First results of the

Phase 2 EMINENCE Trial.” San Francisco, CA. Oral presentation at the

Transcatheter Cardiovascular Therapeutics Conference 2009.

“Comparative effectiveness of radial and femoral approaches to percutaneous

coronary intervention on long-term mortality: A report from the NHLBI Dynamic

Registry.” Atlanta, GA. Poster presentation at the American College of

Cardiology 2010 Scientific Sessions.

Publications:

Journal articles

Page 6 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


1. Cuffe MS, Rao S, O'Connor CM. Heart failure and special therapeutic

considerations in older patients. Clinical Geriatrics 1997;5(3):56-71.

2. Rao SV, Bethel MA, Feinglos MN. Treatment of diabetes mellitus:

implications of the use of oral agents. American Heart Journal 1999;138(5

Pt 1):S334-7.

3. Rao SV, Jollis JG. Reperfusion for acute myocardial infarction: Is the

future in plastics? Mayo Clinic Proceedings 2000;75:991-993.

4. Rao SV, Donahue M, Pi-Sunyer FX, Fuster V. Obesity as a risk factor for

coronary artery disease. American Heart Journal 2001;142(6):1102-1107.

5. Rao SV, Jollis JG. Quality of care in percutaneous coronary intervention.

Cardiovascular Reviews and Reports. March 2002, 165-173.

6. Rao SV, Stamler JS. Erythropoietin, anemia, and orthostatic hypotension:

the evidence mounts… Clinical Autonomic Research 2002;12:141-143.

7. Rao SV, Califf RM. Lessons learned from clinical trials: A roundtable

discussion. Critical Pathways in Cardiology 2003;2:55-59.

8. Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB,

Christenson RH, Hasselblad V, Stebbins A, McNulty S, Newby LK.

Prognostic value of isolated troponin elevation across the spectrum of

chest pain syndromes. The American Journal of Cardiology

2003;91(8):936-940.

9. Rao SV, Kaul P, Newby LK, Lincoff AM, Hochman J, Harrington RA, Mark

DB, Peterson ED. Poverty, process of care, and outcome in acute

coronary syndromes. Journal of the American College of Cardiology

2003;41(11):1948-1954.

10. Rao SV, Jollis JG, Sketch MH Jr. Assessing quality in the cardiac

catheterization laboratory. The American Heart Hospital Journal

2003;1(4):289-296.

11. Wilmer WA, Rovin BH, Hebert CJ, Rao SV, Kumor K, Hebert LA.

Management of glomerular proteinuria: A commentary. Journal of the

American Society of Nephrology 2003;14:3217-3232.

12. Rao SV. Controversies surrounding the use of glycoprotein IIb/IIIa

inhibitors. Critical Pathways in Cardiology 2003;2(4):231-238.

Page 7 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


13. Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG. Socioeconomic

status and outcome after acute myocardial infarction in the elderly.

Archives of Internal Medicine 2004;164:1128-1133.

14. Patel MR, Meine TJ, Radeva J, Curtis L, Rao SV, Schulman KA, Jollis JG.

State-mandated continuing medical education and the use of proven

therapies in patients with an acute myocardial infarction. Journal of the

American College of Cardiology 2004;44:192-198.

15. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PA,

Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. The

relationship of blood transfusion and clinical outcomes in patients with

acute coronary syndromes. JAMA 2004;292:1555-1562.

16. Asher CR, Moliterno DJ, Bhapkar MV, McGuire DK, Rao SV, Holmes DR,

Newby K, Bates ER, Topol EJ. Association of race with complications and

prognosis following acute coronary syndromes. The American Journal of

Cardiology 2004;94(6):792-794.

17. Turer AT, Rao SV. Device therapy in the management of congestive

heart failure. Cardiology in Review 2005;13(3):130-138.

18. Meine TJ, Patel MR, DePuy V, Curtis LH, Rao SV, Gersh BJ, Schulman

KA, Jollis JG. Evidence-based therapies and mortality in patients

hospitalized in December with acute myocardial infarction. Annals of

Internal Medicine 2005;143:481-485.

19. Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV, Gibler

WB, Ohman EM, Peterson ED. The implications of blood transfusions for

patients with non-ST-segment elevation acute coronary syndromes:

Results from the CRUSADE National Quality Improvement Initiative.

Journal of the American College of Cardiology 2005;46:1490-1495.

20. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F,

Mahaffey KW, Califf RM, Harrington RA. The impact of bleeding severity

on clinical outcomes among patients with acute coronary syndromes. The

American Journal of Cardiology 2005;96:1200-1206.

21. Rao SV, O’Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW,

Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RA,

Harrington RA. A comparison of the clinical impact of bleeding measured

by two different classifications among patients with acute coronary

syndromes. Journal of the American College of Cardiology 2006;47:809-

816.

Page 8 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


22. Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating,

and prothrombotic properties of anemia and blood product transfusion.

Journal of Thrombosis and Thrombolysis 2006;21(2):167-174.

23. Rao SV, Shaw RE, Brindis RG, Klein LW, Weintraub WW, Peterson ED.

On- vs. Off-label use of drug-eluting coronary stents in clinical practice

(Report from the American College of Cardiology National Cardiovascular

Data Registry [NCDR]). The American Journal of Cardiology 2006;

97(10): 1478-81.

24. Rao SV, Shaw RE, Brindis RG, Klein LW, Weintraub WS, Krone RJ,

Peterson ED. Patterns and outcomes of drug-eluting coronary stent use

in clinical practice. American Heart Journal 2006;152:321-326.

25. Rao SV, Honeycutt EF, Kandzari DE. Clinical outcomes with drug-eluting

stents following atheroablation therapies. Journal of Invasive Cardiology

2006;18:393-396.

26. Cohen M, Diez J, Fry E, Rao SV, Ferguson JJ 3 rd , Zidar J, Levine G,

Shani J. Strategies for optimizing outcomes in the NSTE-ACS patient The

CATH (cardiac catheterization and antithrombotic therapy in the hospital)

Clinical Consensus Panel Report. Journal of Invasive Cardiology

2006;18(12):617-39.

27. Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand

JP. Bleeding and blood transfusion issues among patients with non STsegment

elevation acute coronary syndromes. European Heart Journal

2007;28:1193-1204.

28. Wallace TW, Rao SV. The challenge of defining bleeding among patients

with acute coronary syndromes. Clinical Cardiology 2007;30(S2):II16-II23.

29. Wang TY, Rao SV. Anemia in patients undergoing percutaneous coronary

intervention: current issues and future directions. American Journal of

Cardiovascular Drugs 2007;7:225-33.

30. Rao SV, Chiswell K, Sun JL, Granger CB, Newby LK, van de Werf F,

White HD, Armstrong PW, Califf RM, Harrington RA. International

variation in the use of blood transfusion among patient with non-STsegment

elevation acute coronary syndromes. The American Journal of

Cardiology 2008;101:25-29.

31. Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf

RM, Harrington RA, Eisenstein EL, Mark DB. Association between

bleeding, blood transfusion, and costs among patients with non ST-

Page 9 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


segment elevation acute coronary syndromes. American Heart Journal

2008;155:369-374.

32. Mehta RH, Rao SV, Ohman EM, Bates ER, Marcucci G, Zhang M, Pieper

KS, Armstrong PW, White HD, Van de Werf F, Califf RM, Granger CB.

Variation in the use of stress testing and outcomes in patients with non

ST-segment elevation acute coronary syndromes: Insights from GUSTO

IIb. European Heart Journal 2008;29:880-887.

33. Roberts WC, Granger CB, Patel MR, Rao SV, Sinnaeve PR, Sulkes DJ.

The Editor’s roundtable: Management and treatment of non-ST-segment

elevation acute coronary syndromes. The American Journal of Cardiology

2008;101:1580-1598.

34. Alexander KP, Chen AY, Wang TY, Rao SV, LaPointe NM, Ohman EM,

Roe MT, Boden WE, Harrington RA, Peterson ED. Transfusion practice

and outcomes in non-ST-segment elevation acute coronary syndromes.

American Heart Journal 2008;155:1047-1053.

35. Kleiman NS, Freedman JE, Tracy PB, Furie BC, Bray PF, Rao SV, Phillips

DR, Storey RF, Rusconi CP, French PA, Steinhubl SR, Becker RC.

Platelets: developmental biology, physiology, and translatable platforms

for preclinical investigation and drug development. Platelets 2008;19:239-

251.

36. Cavender MA, Rao SV, Ohman EM. Major bleeding: management and

risk reduction in acute coronary syndromes. Expert Opinion on

Pharmacotherapy 2008;9:1869-1883.

37. Rao SV, Califf RM, Kramer JM, Peterson Ed, Gross TP, Pepine CJ,

Williams DO, Donohoe D, Waksman R, Mehran R, Krucoff MW.

Postmarket evaluation of breakthrough technologies. The American Heart

Journal 2008;156:201-208.

38. Wang TY, Peterson ED, Dai D, Anderson HV, Rao SV, Brindis RG, Roe

MT. Patterns of cardiac marker surveillance after elective percutaneous

coronary intervention and implications for the use of periprocedural

myocardial infarction as a quality metric: A report from the National

Cardiovascular Data Registry. Journal of the American College of

Cardiology 2008;51:2068-2074.

39. Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED,

Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL. Long-term

clinical outcomes following coronary stenting. Archives of Internal

Medicine 2008;168:1647-1655.

Page 10 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


40. Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS,

Spertus JA, Peterson ED. Antiplatelet therapy use after discharge among

acute myocardial infarction patients with in-hospital bleeding. Circulation

2008;118:2139-2145.

41. Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC,

Rao SV, Reilly RF, Brilakis ES. Comparison of the impact of short ( or =1 year) clopidogrel use following percutaneous

coronary intervention on mortality. American Journal of Cardiology

2008;102:1159-1162.

42. Kim JH, Newby LK, Clare RM, Shaw LK, Lodge AJ, Smith PK, Jolicoeur

EM, Rao SV, Becker RC, Mark DB, Granger CB. Clopidogrel use and

bleeding after coronary artery bypass graft surgery. American Heart

Journal 2008;156:886-892.

43. Cohen M, Alexander KP, Rao SV. Bleeding after antithrombotic therapy in

patients with acute ischemic heart disease: is it the drugs or how we use

them? Journal of Thrombosis & Thrombolysis 2008;26:175-82.

44. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson

ED. Trends in the prevalence and outcomes of the radial and femoral

approaches to percutaneous coronary intervention. JACC: Cardiovascular

Interventions 2008;1:379-386.

45. Rao SV, Kim SYH. Informing the consent process. Circulation:

Healthcare Quality and Outcomes 2008;1:7-8.

46. Happe LE, Rao SV, Horblyuk R, Franklin M, Lunacsek OE, Menditto L.

Consequences of major bleeding in hospitalized patients with non-ST

segment elevation acute coronary syndromes receiving injectable

anticoagulants. Current Medical Research & Opinion 2009;25:413-420.

47. Maynard C, Rao SV, Gregg M, Phillips RC, Reisman M, Tucker E, Goss

JR. The role of out-of-hospital cardiac arrest in predicting hospital mortality

for percutaneous coronary interventions in the Clinical Outcomes

Assessment Program. Journal of Invasive Cardiology 2009;21:1-5.

48. Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ,

Simonton CA, Garg J, Lokhnygina Y, Mancini GBJ, Yeoh E, Buller CE, for

the ACROSS/TOSCA-4 Investigators. Clinical and Angiographic

Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions:

The ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With

Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4)

Trial. JACC: Cardiovascular Interventions 2009;2:97-106.

Page 11 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


49. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang

TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr., Peterson ED,

Alexander KP. Baseline risk of major bleeding in non-ST-segmentelevation

myocardial infarction: the CRUSADE (Can Rapid risk

stratification of Unstable angina patients Suppress ADverse outcomes

with Early implementation of the ACC/AHA Guidelines) Bleeding Score.

Circulation 2009;119:1873-1882.

50. Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou

FS, Roe MT, Peterson ED, Marso SP. Bleeding in patients undergoing

percutaneous coronary intervention: the development of a clinical risk

algorithm from the National Cardiovascular Data Regsitry. Circulation:

Cardiovascular Interventions 2009;2:222-229.

51. Cavender MA, Milford-Beland S, Roe MT, Peterson ED, Weintraub WS,

Rao SV. Prevalence, predictors, and in-hospital outcomes of non-infarct

artery intervention during primary percutaneous coronary intervention for

ST-segment elevation myocardial infarction (from the National

Cardiovascular Data Registry). American Journal of Cardiology

2009;104:507-513.

52. Povsic TJ, Adams SD, Zavodni KL, Kelly F, Melton LG, Rao SV, Najjar

SS, Harrington RA, Peterson ED. Aldehyde dehydrogenase activity

allows reliable EPC enumeration in stored peripheral blood samples.

Journal of Thrombosis & Thrombolysis 2009;28:259-265.

53. Melloni C, Fier I, Roach J, Kosinski AS, Broderick S, Sigmon K, Myles S,

Becker RC, Rao SV on behalf of the EMINENCE Investigators. Design

and rationale of the Evaluation of M118 IN pErcutaNeous Coronary

intErvention (EMINENCE) Trial. American Heart Journal 2009;158:726-

733.

54. Rao SV. Using procedural approaches to reduce complications related to

percutaneous coronary interventions. Journal of Invasive Cardiology

2009;21 (8 Suppl A):21A-24A.

55. Vavalle JP, Rao SV. The association between the transradial approach for

percutaneous coronary interventions and bleeding. Journal of Invasive

Cardiology 2009;21(8 Suppl A):21A-24A.

56. Rao SV. Strategies to reduce bleeding among patients with ischemic

heart disease treated with antiplatelet therapies. American Journal of

Cardiology 2009;104(5 suppl):60C-63C.

57. Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP,

Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R,

Page 12 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


Lee KL, Moscucci M, Harrington RA on behalf of the Academic Bleeding

Consensus Multidisciplinary Working Group. Standardized reporting of

bleeding complications for clinical investigations in acute coronary

syndromes: a proposal from the academic bleeding consensus

(ABC) multidisciplinary working group. American Heart Journal

2009;158:881-886.

58. Rao SV, Ohman EM. Anticoagulant therapy for percutaneous coronary

intervention. Ciruclation: Cardiovascular Interventions 2010;3:80-88.

59. Rao SV, Melloni C, Myles-DiMauro S, Broderick S, Kosinski AS, Kleiman

NS, Dzavik V, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander

JH, Fier I, Roach J, Becker RC. Evaluation of a new heparin agent in

percutaneous coronary intervention: Results of the Phase 2 Evaluation of

M118 IN pErcutaNeous Coronary intervention (EMINENCE) trial.

Circulation 2010;121:1713-1721.

60. Rao SV, Cohen MG, Kandzari DH, Bertrand OF, Gilchrist IC. The

transradial approach to percutaneous coronary intervention: Historical

perspective, current concepts, and future directions. JACC (in press).

61. Rao SV, Califf RM. Is old blood bad blood? American Heart Journal (in

press).

62. Rao SV. Scaling new heights in quality improvement. JACC 2010 (in

press).

Book chapters

1. McGuire DK, Rao SV. Epidemiology of Diabetes and Cardiovascular

Disease. In: The Handbook of Diabetes and Cardiovascular Disease.

Steven P. Marso, editor. Remedica Publishing, London UK, 2003.

2. Rao SV, McGuire DK. Epidemiology of Diabetes and Cardiovascular

Disease. In: Diabetes and Cardiovascular Disease. Steven P. Marso MD,

Alan Stern MD, editors.

3. Rao SV, Newby LK. Risk stratification in acute coronary syndromes. In:

The Year In Interventional Cardiology 2003. Clinical Publishing Ltd.,

Oxford UK, 2003.

4. Rao SV, Newby LK. Risk stratification in acute coronary syndromes. In:

The Year In Interventional Cardiology 2004. Clinical Publishing Ltd.,

Oxford UK, 2004.

Page 13 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010


5. Rao SV, Zidar FJ, Zidar JP. Iliac angioplasty and stenting. In:

Interventional Cardiology. McGraw-Hill Publishing. Spencer B. King III

MD, Alan C. Yeung MD, editors.

Alternative media

Host, Duke Clinical Medicine Series. “Cardiovascular Cath Lab Conference”

available at http://cathlabconference.dcri.duke.edu; 2006 - present

Rao SV. Day in Review: American College of Cardiology Annual Scientific

Sessions 2004. www.theheart.org

Rao SV. Day in Review: American College of Cardiology Annual Scientific

Sessions 2003. www.theheart.org

Rao SV. Day in Review: American Heart Association Scientific Sessions 2002.

www.theheart.org

Rao SV. Day in Review: American College of Cardiology Annual Scientific

Sessions 2002. www.theheart.org

Rao S. Commentary: Review of the ESPRIT Trial. MD Consult Cardiology 2002.

http://www.mdconsult.com

Rao SV. Day in Review: American Heart Association Scientific Sessions 2001.

www.theheart.org

Page 14 of 14 Curriculum Vitae, Sunil V. Rao

5/1/2010

More magazines by this user
Similar magazines